Mark A. Wainberg – What if HIV could not develop resistance to a new integrase inhibitor when that compound is used in first-line therapy?
Mark A. Wainberg, Ph.D.
Professor of Microbiology and Immunology, McGill University, Montreal, Canada
Director, McGill AIDS Centre, Lady Davis Institute
Jewish General Hospital
“What if HIV could not develop resistance to a new integrase inhibitor when that compound is used in first-line therapy?”
Mark Wainberg slides (679)
UCLA CFAR/AIDS Institute Grand Rounds
This monthly lecture series, which is offered by the UCLA CFAR / AIDS Institute, consists of hour-long lunchtime lectures, delivered by invited guests or distinguished members of the Institute faculty, on a broad range of subjects. The aims of the program are to highlight important developments in AIDS-related research, encourage collaborations between UCLA investigators and invited speakers, interest young investigators in AIDS research, and provide information about new findings and new funding opportunities.